Prospective evaluation of hydroxychloroquine in pediatric interstitial lung diseases: Study protocol for an investigator-initiated, randomized controlled, parallel-group clinical trial

BACKGROUND: Interstitial lung diseases in children (chILD) are rare and consist of many different entities that affect the parenchyma of the lungs, leading to a chronic lung disease. The natural course of many of these diseases is connected with a high morbidity and significant mortality. Symptomati...

Descripción completa

Detalles Bibliográficos
Autores principales: Griese, Matthias, Köhler, Meike, Witt, Sabine, Sebah, Daniela, Kappler, Matthias, Wetzke, Martin, Schwerk, Nicolaus, Emiralioglu, Nagehan, Kiper, Nural, Kronfeld, Kai, Ruckes, Christian, Rock, Hans, Anthony, Gisela, Seidl, Elias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118852/
https://www.ncbi.nlm.nih.gov/pubmed/32245508
http://dx.doi.org/10.1186/s13063-020-4188-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118852/
https://www.ncbi.nlm.nih.gov/pubmed/32245508
http://dx.doi.org/10.1186/s13063-020-4188-4

Ejemplares similares